株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポイントオブケア診断の世界市場 - 成長率、動向および予測(2019年~2024年)

Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 660545
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.24円で換算しております。
Back to Top
ポイントオブケア診断の世界市場 - 成長率、動向および予測(2019年~2024年) Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 114 Pages
概要

世界のポイントオブケア診断市場では、予測期間中に9.8%のCAGRを記録すると予想されています。市場の成長を担う主な要因の1つは、発展途上国における慢性疾患および感染症の罹患率の上昇です。糖尿病、リウマチ、または癌などの慢性疾患の罹患率は、高齢者人口の増加、座りがちな生活習慣、不健康な食習慣、および環境要因など、様々な理由で世界的に増加しています。例えば、世界中で毎年3,800万人以上の人々が慢性疾患で死亡しています。心血管疾患は、年間1,750万人と、慢性疾患による死亡人数の大部分を占め、癌(8,200万人)、呼吸器疾患(400万人)、および糖尿病(150万人)が続いています。これらの疾患は、慢性疾患による死亡全体の82%を占めています。ポイントオブケア診断は、検査を実施するために患者のいる場所からサンプルが収集されるため、世界中の様々な患者に広く受け入れられており、その結果は、マイクロ流体、チップ、そしてナノ診断を利用しているので、非常に短い時間で得られます。

当レポートでは、世界のポイントオブケア診断市場を調査し、全体的な市場動向、製品・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 イントロダクション

  • 調査の成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 発展途上国における慢性疾患および感染症の罹患率の上昇
    • 新規イムノアッセイ技術に対する規制承認数の増加
    • 技術の進歩
    • 家庭用POCデバイスの使用の増加
  • 市場阻害要因
    • 大手企業による製品リコールが掻き立てる新規参入者の意欲
    • 厳格な規制方針と償還問題
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/買い手の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競合の激しさ

第5章 市場セグメンテーション

  • 製品別
    • グルコースモニタリングキット
    • 心代謝モニタリングキット
    • 妊娠・生殖能力検査キット
    • 感染症検査キット
    • コレステロールテストストリップ
    • 血液検査キット
    • その他の商品
  • エンドユーザー別
    • 病院/救命救急センター
    • 外来診療所
    • 研究所
    • 他のエンドユーザー
  • 地域
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott
    • Siemens AG
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • Instrumentation Laboratory
    • Johnson and Johnson
    • Nova Biomedical
    • Qiagen
    • F. Hoffmann-La Roche Ltd

第7章 市場機会および将来動向

目次
Product Code: 55791

Market Overview

The point-of-care diagnostics market is expected to register a CAGR of 9.8%, over the forecast period. One of the major factors responsible for the growth of the market is the rising prevalence of chronic and infectious diseases in developing economies. The prevalence of chronic diseases, like diabetes, rheumatism, or cancer, is increasing globally, due to various reasons, such as an increase in geriatric population, sedentary lifestyles, unhealthy food habits, and environmental factors. For instance, chronic diseases kill more than 38 million people each year, globally. Cardiovascular diseases account for most chronic disease deaths, or 17.5 million people, annually, followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). The aforementioned diseases account for 82% of all the chronic disorder deaths. Point-of-care diagnostics is gaining wide acceptance by different patients across the world, as samples are collected from the patient's location for performing tests, and the results can be achieved in very less time, due to the use of micro fluids, chips, and nano diagnostics.

Factors, such as the increasing number of regulatory approvals for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices, are expected to drive the market growth, over the forecasted period.

Scope of the Report

Point-of-care testing diagnostics have many advantages, which allows patient diagnoses at many places, such as in the physician's office, an ambulance, the home, the field, or in the hospital. The results of care are timely and offer rapid treatment to the patient.

Key Market Trends

Blood Glucose Testing is Expected to Hold Major Revenue Share in the Type of Products Segment

Blood glucose testing point-of-care diagnostics captured the largest share in 2018, due to the success of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose level is of vital importance for diabetic patients, which has encouraged the adoption of POC among the diabetic patients in this segment. Other advantages associated with hand-held glucose meters are the portability and easy operability. Rising prevalence of diabetes across the world is expected to boost the segment growth in the future.

North America Dominates the Market and is Expected to do Same in the Forecast Period

Currently, North America dominates the market for point-of care-diagnostics, and is expected to continue its stronghold for a few more years. In the North America region, the United States holds the largest market share. This can be majorly attributed due to the growing geriatric population base in the country, as well as the factors, such as the increasing prevalence of diseases and the favorable government regulations and initiatives undertaken for the development of healthcare infrastructure.

Competitive Landscape

The point-of-care diagnostics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With rising prevalnce of diseases and increasing number of aging population, other players are also expcted to enter into the market. Some of the major players of the market are Abbott, Siemens AG, Becton, Dickinson and Company, Johnson and Johnson, and F. Hoffmann-La Roche Ltd, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic and Infectious Diseases in Developing Economies
    • 4.2.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques
    • 4.2.3 Technological Advancements
    • 4.2.4 Rising Usage of Home-based POC Devices
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls by Major Players Demotivate New Entrants
    • 4.3.2 Stringent Regulatory Policies and Reimbursement Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Glucose Monitoring Kit
    • 5.1.2 Cardio-metabolic Monitoring Kit
    • 5.1.3 Pregnancy and Fertility Testing Kit
    • 5.1.4 Infectious Disease Testing Kit
    • 5.1.5 Cholesterol Test Strip
    • 5.1.6 Hematology Testing Kit
    • 5.1.7 Other Products
  • 5.2 By End User
    • 5.2.1 Hospital/Critical Care Setting
    • 5.2.2 Ambulatory Care Setting
    • 5.2.3 Research Laboratory
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Siemens AG
    • 6.1.3 Beckman Coulter Inc.
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Instrumentation Laboratory
    • 6.1.6 Johnson and Johnson
    • 6.1.7 Nova Biomedical
    • 6.1.8 Qiagen
    • 6.1.9 F. Hoffmann-La Roche Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top